Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study




Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, Lavikainen P, Jula A, Junnila SYT, Kettunen R, Huupponen R

PublisherWILEY-BLACKWELL

2011

British Journal of Clinical Pharmacology

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

BRIT J CLIN PHARMACO

5

71

5

766

776

11

0306-5251

DOIhttps://doi.org/10.1111/j.1365-2125.2010.03895.x



In patients with diabetes, good adherence to statins predicts reduced incidence of MCEs irrespective of the presence of CHD at statin initiation.



Last updated on 2024-26-11 at 22:57